SPRIM Global Investments and OneIM Launch $300 Million Joint Venture to Accelerate Clinical Study Financing SPRIM Global Investments announces a $300 million joint venture with OneIM aimed at fast-tracking funding for clinical studies across various biotech sectors.

SPRIM Global Investments and OneIM Launch $300 Million Joint Venture to Accelerate Clinical Study Financing #New_York #Singapore #Clinical_Trials #SPRIM_Global #OneIM

SPRIM Global Investments and OneIM Announce $300 Million Joint Venture to Boost Clinical Trial Funding A new $300 million partnership between SPRIM Global Investments and OneIM aims to enhance financing for clinical trials, supporting biotech innovations.

SPRIM Global Investments and OneIM Announce $300 Million Joint Venture to Boost Clinical Trial Funding #USA #New_York #Clinical_Trials #SPRIM_Global #OneIM

SPRIM Global Investments and OneIM Launch $300 Million Joint Venture for Clinical Trials SPRIM Global Investments and OneIM unveil a $300 million joint venture aimed at enhancing clinical trial financing, fostering innovation in life sciences.

SPRIM Global Investments and OneIM Launch $300 Million Joint Venture for Clinical Trials #Singapore #Clinical_Trials #SPRIM_Global #OneIM